

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.45825917 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.95012186 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 4.79592133 |
| 4 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.61436455 |
| 5 | vocalization behavior (GO:0071625) | 4.58340293 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.49805847 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.40743599 |
| 8 | locomotory exploration behavior (GO:0035641) | 4.33283434 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 4.31332193 |
| 10 | glutamate secretion (GO:0014047) | 4.27049310 |
| 11 | regulation of synaptic vesicle transport (GO:1902803) | 4.03492599 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.00411846 |
| 13 | protein localization to synapse (GO:0035418) | 3.94924434 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.92078445 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.87719201 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.86643238 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.80700320 |
| 18 | neurotransmitter secretion (GO:0007269) | 3.76842061 |
| 19 | neuronal action potential propagation (GO:0019227) | 3.75550835 |
| 20 | proline transport (GO:0015824) | 3.71754703 |
| 21 | detection of calcium ion (GO:0005513) | 3.71207526 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 3.60199124 |
| 23 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.59540013 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 3.55022067 |
| 25 | exploration behavior (GO:0035640) | 3.51081419 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.49666142 |
| 27 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.46996057 |
| 28 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.46115882 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 3.45508845 |
| 30 | activation of protein kinase A activity (GO:0034199) | 3.43603220 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.43338026 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.40010504 |
| 33 | protein targeting to Golgi (GO:0000042) | 3.39143376 |
| 34 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.28148928 |
| 35 | chemosensory behavior (GO:0007635) | 3.26302195 |
| 36 | innervation (GO:0060384) | 3.26185027 |
| 37 | cellular potassium ion homeostasis (GO:0030007) | 3.23810639 |
| 38 | presynaptic membrane assembly (GO:0097105) | 3.23530797 |
| 39 | positive regulation of membrane potential (GO:0045838) | 3.22997619 |
| 40 | layer formation in cerebral cortex (GO:0021819) | 3.22185296 |
| 41 | membrane depolarization during action potential (GO:0086010) | 3.21753643 |
| 42 | long-term memory (GO:0007616) | 3.20801149 |
| 43 | neurotransmitter transport (GO:0006836) | 3.20061663 |
| 44 | neuron recognition (GO:0008038) | 3.16830874 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.16041855 |
| 46 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15088783 |
| 47 | vesicle transport along microtubule (GO:0047496) | 3.14420506 |
| 48 | regulation of postsynaptic membrane potential (GO:0060078) | 3.14196805 |
| 49 | macroautophagy (GO:0016236) | 3.13571607 |
| 50 | insulin secretion (GO:0030073) | 3.12820771 |
| 51 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.11702427 |
| 52 | positive regulation of neurotransmitter transport (GO:0051590) | 3.09755667 |
| 53 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.07968388 |
| 54 | establishment of protein localization to Golgi (GO:0072600) | 3.07699133 |
| 55 | glandular epithelial cell differentiation (GO:0002067) | 3.06202567 |
| 56 | potassium ion homeostasis (GO:0055075) | 3.05545486 |
| 57 | regulation of vesicle fusion (GO:0031338) | 3.04584654 |
| 58 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.03945811 |
| 59 | transmission of nerve impulse (GO:0019226) | 3.03803523 |
| 60 | gamma-aminobutyric acid transport (GO:0015812) | 3.03496952 |
| 61 | synaptic vesicle endocytosis (GO:0048488) | 3.02546652 |
| 62 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.02381353 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.02303688 |
| 64 | postsynaptic membrane organization (GO:0001941) | 3.02275892 |
| 65 | long-term synaptic potentiation (GO:0060291) | 3.00332218 |
| 66 | regulation of synapse structural plasticity (GO:0051823) | 2.99155187 |
| 67 | neuromuscular process controlling posture (GO:0050884) | 2.99121278 |
| 68 | auditory receptor cell differentiation (GO:0042491) | 2.97892065 |
| 69 | regulation of synaptic plasticity (GO:0048167) | 2.94856090 |
| 70 | response to histamine (GO:0034776) | 2.94643509 |
| 71 | synapse assembly (GO:0007416) | 2.93058139 |
| 72 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.92708577 |
| 73 | dendrite morphogenesis (GO:0048813) | 2.92468433 |
| 74 | Golgi to endosome transport (GO:0006895) | 2.92406652 |
| 75 | regulation of Rac protein signal transduction (GO:0035020) | 2.90818753 |
| 76 | dendritic spine morphogenesis (GO:0060997) | 2.90735805 |
| 77 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.90609562 |
| 78 | axonal fasciculation (GO:0007413) | 2.89083824 |
| 79 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.89057396 |
| 80 | positive regulation of macroautophagy (GO:0016239) | 2.89037549 |
| 81 | presynaptic membrane organization (GO:0097090) | 2.88246839 |
| 82 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.87885380 |
| 83 | organelle transport along microtubule (GO:0072384) | 2.86995607 |
| 84 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.86208623 |
| 85 | calcium ion-dependent exocytosis (GO:0017156) | 2.84947466 |
| 86 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.84796397 |
| 87 | inner ear receptor cell development (GO:0060119) | 2.84786128 |
| 88 | regulation of neurotransmitter levels (GO:0001505) | 2.84431523 |
| 89 | cerebellar Purkinje cell layer development (GO:0021680) | 2.84388504 |
| 90 | inositol phosphate catabolic process (GO:0071545) | 2.84083259 |
| 91 | social behavior (GO:0035176) | 2.82273266 |
| 92 | intraspecies interaction between organisms (GO:0051703) | 2.82273266 |
| 93 | membrane depolarization (GO:0051899) | 2.81892335 |
| 94 | membrane hyperpolarization (GO:0060081) | 2.80041276 |
| 95 | positive regulation of synapse maturation (GO:0090129) | 2.79914657 |
| 96 | regulation of exocytosis (GO:0017157) | 2.79203515 |
| 97 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.78334278 |
| 98 | positive regulation of exocytosis (GO:0045921) | 2.77684844 |
| 99 | regulation of neurotransmitter transport (GO:0051588) | 2.76669080 |
| 100 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.75682023 |
| 101 | suckling behavior (GO:0001967) | 2.74983340 |
| 102 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.74006364 |
| 103 | cilium movement (GO:0003341) | 2.73539412 |
| 104 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.72380713 |
| 105 | establishment of synaptic vesicle localization (GO:0097480) | 2.72033380 |
| 106 | synaptic vesicle transport (GO:0048489) | 2.72033380 |
| 107 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.71219536 |
| 108 | synaptic transmission (GO:0007268) | 2.70697830 |
| 109 | startle response (GO:0001964) | 2.70626599 |
| 110 | COPI coating of Golgi vesicle (GO:0048205) | 2.70489727 |
| 111 | Golgi transport vesicle coating (GO:0048200) | 2.70489727 |
| 112 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.69955118 |
| 113 | epithelial cell fate commitment (GO:0072148) | 2.69685671 |
| 114 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.69328579 |
| 115 | glycerophospholipid catabolic process (GO:0046475) | 2.68847070 |
| 116 | female mating behavior (GO:0060180) | 2.68538553 |
| 117 | cell communication by electrical coupling (GO:0010644) | 2.67230826 |
| 118 | behavioral response to ethanol (GO:0048149) | 2.66673220 |
| 119 | myelin maintenance (GO:0043217) | 2.66200379 |
| 120 | polyol catabolic process (GO:0046174) | 2.64156127 |
| 121 | axoneme assembly (GO:0035082) | 2.63831254 |
| 122 | cardiac conduction (GO:0061337) | 2.62757496 |
| 123 | intestinal epithelial cell development (GO:0060576) | 2.62071972 |
| 124 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.61542606 |
| 125 | auditory behavior (GO:0031223) | 2.59855474 |
| 126 | cerebellar granule cell differentiation (GO:0021707) | 2.57832742 |
| 127 | inositol phosphate-mediated signaling (GO:0048016) | 2.56555294 |
| 128 | signal release (GO:0023061) | 2.56459562 |
| 129 | axonemal dynein complex assembly (GO:0070286) | 2.54717053 |
| 130 | inositol phosphate dephosphorylation (GO:0046855) | 2.53876901 |
| 131 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.53876901 |
| 132 | regulation of autophagic vacuole assembly (GO:2000785) | 2.52803608 |
| 133 | regulation of neurotransmitter uptake (GO:0051580) | 2.52762983 |
| 134 | righting reflex (GO:0060013) | 2.52409504 |
| 135 | cellular ketone body metabolic process (GO:0046950) | 2.52257260 |
| 136 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.51335754 |
| 137 | cochlea development (GO:0090102) | 2.51047611 |
| 138 | biotin metabolic process (GO:0006768) | 2.48316824 |
| 139 | peptide hormone processing (GO:0016486) | 2.46448547 |
| 140 | peptide hormone secretion (GO:0030072) | 2.44341510 |
| 141 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.44032005 |
| 142 | endocrine pancreas development (GO:0031018) | 2.43322516 |
| 143 | positive regulation of gluconeogenesis (GO:0045722) | 2.42039104 |
| 144 | apical protein localization (GO:0045176) | 2.41436471 |
| 145 | membrane repolarization during action potential (GO:0086011) | 2.41021731 |
| 146 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.40327358 |
| 147 | positive regulation of insulin secretion (GO:0032024) | 2.39992527 |
| 148 | epithelial cilium movement (GO:0003351) | 2.38951461 |
| 149 | regulation of insulin secretion (GO:0050796) | 2.35843913 |
| 150 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.35110933 |
| 151 | peptide secretion (GO:0002790) | 2.34523146 |
| 152 | nitric oxide biosynthetic process (GO:0006809) | 2.33789378 |
| 153 | calcium ion import (GO:0070509) | 2.32469242 |
| 154 | protein localization to cilium (GO:0061512) | 2.32237865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.81551294 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.93913058 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.76814902 |
| 4 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65444318 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.64220481 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.57696612 |
| 7 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26499252 |
| 8 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.25968715 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23665889 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20809169 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.19788919 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.17873884 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.17873884 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.14723809 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.14211119 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.11636594 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.10416021 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.08375660 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.03086774 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.02437899 |
| 21 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.93213918 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90789562 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87684217 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.86668080 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85786405 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.84473407 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.83276226 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.83078898 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.81850560 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.81691413 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80411648 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.73547016 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.71565007 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71560391 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61719211 |
| 36 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.60183482 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59685125 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.59327892 |
| 39 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.58134762 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56958569 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56953751 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55405208 |
| 43 | STAT3_23295773_ChIP-Seq_U87_Human | 1.55220874 |
| 44 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.55161110 |
| 45 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.51534846 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50242779 |
| 47 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46714059 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.46341091 |
| 49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45040708 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.44358188 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44264820 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.44182352 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44157810 |
| 54 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42900030 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39735753 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39220242 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.39075686 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35183779 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 1.34579625 |
| 60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34429975 |
| 61 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.34095897 |
| 62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.33131199 |
| 63 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30395712 |
| 64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27820052 |
| 65 | AR_19668381_ChIP-Seq_PC3_Human | 1.27112275 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26890295 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26117095 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25288856 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23468028 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20075731 |
| 71 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.19093938 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18702120 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16391451 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.14994297 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13986303 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13883728 |
| 77 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13657477 |
| 78 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13592794 |
| 79 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13058345 |
| 80 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12779803 |
| 81 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12234834 |
| 82 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11858361 |
| 83 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.11651533 |
| 84 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11366916 |
| 85 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10244543 |
| 86 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08420882 |
| 87 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08341874 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08152319 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07704096 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07411420 |
| 91 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06542039 |
| 92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06489502 |
| 93 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06486722 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06143889 |
| 95 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05407891 |
| 96 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.04667911 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03952568 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03554186 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03049516 |
| 100 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02682885 |
| 101 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02154537 |
| 102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00071436 |
| 103 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98151203 |
| 104 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97525877 |
| 105 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97325868 |
| 106 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97156858 |
| 107 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97088917 |
| 108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95816713 |
| 109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94668758 |
| 110 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.94473906 |
| 111 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93996200 |
| 112 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93183385 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92868138 |
| 114 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92847821 |
| 115 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91394864 |
| 116 | JUN_21703547_ChIP-Seq_K562_Human | 0.91121165 |
| 117 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91100639 |
| 118 | VDR_22108803_ChIP-Seq_LS180_Human | 0.91086864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.91105003 |
| 2 | MP0004270_analgesia | 3.95312589 |
| 3 | MP0003880_abnormal_central_pattern | 3.68980199 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.49460091 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 2.94035650 |
| 6 | MP0009745_abnormal_behavioral_response | 2.85630982 |
| 7 | MP0009046_muscle_twitch | 2.83733320 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.81123135 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 2.73290692 |
| 10 | MP0002064_seizures | 2.64210480 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.56945474 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.53669714 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.51937453 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.37673663 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.32182714 |
| 16 | MP0002272_abnormal_nervous_system | 2.31302435 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.24416782 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.20040423 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.14493859 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.12262808 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.04632219 |
| 22 | MP0001486_abnormal_startle_reflex | 2.03478140 |
| 23 | MP0006276_abnormal_autonomic_nervous | 2.02398721 |
| 24 | MP0003123_paternal_imprinting | 1.98848896 |
| 25 | MP0001970_abnormal_pain_threshold | 1.97863073 |
| 26 | MP0001440_abnormal_grooming_behavior | 1.94621328 |
| 27 | MP0003122_maternal_imprinting | 1.88633474 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.85485728 |
| 29 | MP0002736_abnormal_nociception_after | 1.83560304 |
| 30 | MP0003283_abnormal_digestive_organ | 1.83249326 |
| 31 | MP0003787_abnormal_imprinting | 1.81129063 |
| 32 | MP0002184_abnormal_innervation | 1.80790240 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.78283131 |
| 34 | MP0004858_abnormal_nervous_system | 1.78171025 |
| 35 | MP0002822_catalepsy | 1.77231446 |
| 36 | MP0001984_abnormal_olfaction | 1.76142825 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.73210063 |
| 38 | MP0004924_abnormal_behavior | 1.63479794 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.63479794 |
| 40 | MP0003879_abnormal_hair_cell | 1.62203516 |
| 41 | MP0004043_abnormal_pH_regulation | 1.57958230 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.55177316 |
| 43 | MP0008569_lethality_at_weaning | 1.53642306 |
| 44 | MP0003329_amyloid_beta_deposits | 1.50257904 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.50168838 |
| 46 | MP0000778_abnormal_nervous_system | 1.48851058 |
| 47 | MP0002693_abnormal_pancreas_physiology | 1.47344372 |
| 48 | MP0008877_abnormal_DNA_methylation | 1.45668286 |
| 49 | MP0005220_abnormal_exocrine_pancreas | 1.45289889 |
| 50 | MP0000955_abnormal_spinal_cord | 1.45246895 |
| 51 | MP0002163_abnormal_gland_morphology | 1.44268731 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.41991696 |
| 53 | MP0003195_calcinosis | 1.40532756 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.39178694 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.38342884 |
| 56 | MP0002009_preneoplasia | 1.34781037 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.30432407 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.29128127 |
| 59 | MP0001756_abnormal_urination | 1.26710334 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.24606000 |
| 61 | MP0003633_abnormal_nervous_system | 1.22993181 |
| 62 | MP0001188_hyperpigmentation | 1.21004827 |
| 63 | MP0001944_abnormal_pancreas_morphology | 1.20806865 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 1.18126825 |
| 65 | MP0010678_abnormal_skin_adnexa | 1.16104847 |
| 66 | MP0006072_abnormal_retinal_apoptosis | 1.15185168 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 1.14179974 |
| 68 | MP0001529_abnormal_vocalization | 1.14031907 |
| 69 | MP0004133_heterotaxia | 1.13576802 |
| 70 | MP0002229_neurodegeneration | 1.12261890 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.11689434 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.11274090 |
| 73 | MP0002876_abnormal_thyroid_physiology | 1.06402915 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 1.06399520 |
| 75 | MP0004019_abnormal_vitamin_homeostasis | 1.05868813 |
| 76 | MP0001986_abnormal_taste_sensitivity | 1.04861680 |
| 77 | MP0005448_abnormal_energy_balance | 1.03155780 |
| 78 | MP0004142_abnormal_muscle_tone | 1.01084708 |
| 79 | MP0010329_abnormal_lipoprotein_level | 1.00313294 |
| 80 | MP0003631_nervous_system_phenotype | 1.00278308 |
| 81 | MP0005535_abnormal_body_temperature | 0.98477437 |
| 82 | MP0003011_delayed_dark_adaptation | 0.96765170 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.95258212 |
| 84 | MP0001905_abnormal_dopamine_level | 0.95158076 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 0.94532377 |
| 86 | MP0002152_abnormal_brain_morphology | 0.94507339 |
| 87 | MP0001299_abnormal_eye_distance/ | 0.94480764 |
| 88 | MP0002069_abnormal_eating/drinking_beha | 0.94252983 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.93674101 |
| 90 | MP0003045_fibrosis | 0.92604986 |
| 91 | MP0005367_renal/urinary_system_phenotyp | 0.91262767 |
| 92 | MP0000516_abnormal_urinary_system | 0.91262767 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.90021493 |
| 94 | MP0005332_abnormal_amino_acid | 0.88696748 |
| 95 | MP0002139_abnormal_hepatobiliary_system | 0.88195291 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.86430190 |
| 97 | MP0003634_abnormal_glial_cell | 0.85480038 |
| 98 | MP0004085_abnormal_heartbeat | 0.85102680 |
| 99 | MP0004885_abnormal_endolymph | 0.85001748 |
| 100 | MP0005187_abnormal_penis_morphology | 0.84608664 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.84445823 |
| 102 | MP0004742_abnormal_vestibular_system | 0.84257582 |
| 103 | MP0000383_abnormal_hair_follicle | 0.83748826 |
| 104 | MP0000538_abnormal_urinary_bladder | 0.83279368 |
| 105 | MP0002653_abnormal_ependyma_morphology | 0.82996010 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.82068689 |
| 107 | MP0005365_abnormal_bile_salt | 0.81781335 |
| 108 | MP0001664_abnormal_digestion | 0.77272582 |
| 109 | MP0005310_abnormal_salivary_gland | 0.77221608 |
| 110 | MP0001963_abnormal_hearing_physiology | 0.76303966 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.73981277 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.73659059 |
| 113 | MP0003690_abnormal_glial_cell | 0.73252983 |
| 114 | MP0003953_abnormal_hormone_level | 0.73063419 |
| 115 | MP0003890_abnormal_embryonic-extraembry | 0.72952819 |
| 116 | MP0003121_genomic_imprinting | 0.70650622 |
| 117 | MP0003632_abnormal_nervous_system | 0.69055559 |
| 118 | MP0000678_abnormal_parathyroid_gland | 0.66623609 |
| 119 | MP0002752_abnormal_somatic_nervous | 0.66600362 |
| 120 | MP0005499_abnormal_olfactory_system | 0.65577031 |
| 121 | MP0005394_taste/olfaction_phenotype | 0.65577031 |
| 122 | MP0000604_amyloidosis | 0.63145054 |
| 123 | MP0001177_atelectasis | 0.62059802 |
| 124 | MP0002090_abnormal_vision | 0.61512194 |
| 125 | MP0005253_abnormal_eye_physiology | 0.60353922 |
| 126 | MP0008872_abnormal_physiological_respon | 0.58789079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.18841082 |
| 2 | Focal seizures (HP:0007359) | 4.95213592 |
| 3 | Atonic seizures (HP:0010819) | 4.65172523 |
| 4 | Myokymia (HP:0002411) | 4.64675928 |
| 5 | Visual hallucinations (HP:0002367) | 4.60306617 |
| 6 | Febrile seizures (HP:0002373) | 4.18965646 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.12720697 |
| 8 | Absence seizures (HP:0002121) | 4.07604532 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 3.79405379 |
| 10 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.76472590 |
| 11 | Dialeptic seizures (HP:0011146) | 3.67009762 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.60013464 |
| 13 | Action tremor (HP:0002345) | 3.41052473 |
| 14 | Epileptiform EEG discharges (HP:0011182) | 3.37597182 |
| 15 | Agitation (HP:0000713) | 3.36776356 |
| 16 | EEG with generalized epileptiform discharges (HP:0011198) | 3.28230523 |
| 17 | Truncal ataxia (HP:0002078) | 3.10332921 |
| 18 | Congenital malformation of the right heart (HP:0011723) | 3.09080234 |
| 19 | Double outlet right ventricle (HP:0001719) | 3.09080234 |
| 20 | Hypsarrhythmia (HP:0002521) | 3.08220528 |
| 21 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.97392995 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 2.94899278 |
| 23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.94167616 |
| 24 | Pheochromocytoma (HP:0002666) | 2.91280789 |
| 25 | Papilledema (HP:0001085) | 2.90101362 |
| 26 | Hyperventilation (HP:0002883) | 2.85117626 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 2.84549135 |
| 28 | Hypoglycemic coma (HP:0001325) | 2.80044476 |
| 29 | Ketoacidosis (HP:0001993) | 2.76917420 |
| 30 | Impaired smooth pursuit (HP:0007772) | 2.75220718 |
| 31 | Excessive salivation (HP:0003781) | 2.73403604 |
| 32 | Drooling (HP:0002307) | 2.73403604 |
| 33 | Broad-based gait (HP:0002136) | 2.71264330 |
| 34 | Depression (HP:0000716) | 2.70717530 |
| 35 | Rhinitis (HP:0012384) | 2.70717338 |
| 36 | Amblyopia (HP:0000646) | 2.68147205 |
| 37 | Anxiety (HP:0000739) | 2.62413098 |
| 38 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.59736285 |
| 39 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.59736285 |
| 40 | Abnormal ciliary motility (HP:0012262) | 2.58341711 |
| 41 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.54145383 |
| 42 | Hyperglycemia (HP:0003074) | 2.53848918 |
| 43 | Ankle clonus (HP:0011448) | 2.50029570 |
| 44 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.48522812 |
| 45 | Testicular atrophy (HP:0000029) | 2.47949895 |
| 46 | Absent/shortened dynein arms (HP:0200106) | 2.47074367 |
| 47 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.47074367 |
| 48 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.46563100 |
| 49 | Genetic anticipation (HP:0003743) | 2.45745835 |
| 50 | Neuroendocrine neoplasm (HP:0100634) | 2.44162148 |
| 51 | Large for gestational age (HP:0001520) | 2.42378844 |
| 52 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.42353353 |
| 53 | Chronic bronchitis (HP:0004469) | 2.41076052 |
| 54 | Dysdiadochokinesis (HP:0002075) | 2.39779123 |
| 55 | Enlarged penis (HP:0000040) | 2.39719643 |
| 56 | Dysmetria (HP:0001310) | 2.39315207 |
| 57 | Hypothermia (HP:0002045) | 2.38733415 |
| 58 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.38420715 |
| 59 | Failure to thrive in infancy (HP:0001531) | 2.37491491 |
| 60 | Increased circulating renin level (HP:0000848) | 2.37159557 |
| 61 | Testicular neoplasm (HP:0010788) | 2.36966547 |
| 62 | Poor eye contact (HP:0000817) | 2.36887102 |
| 63 | Decreased circulating renin level (HP:0003351) | 2.34078283 |
| 64 | Blue irides (HP:0000635) | 2.33417596 |
| 65 | Termporal pattern (HP:0011008) | 2.29722916 |
| 66 | Insidious onset (HP:0003587) | 2.29722916 |
| 67 | Impaired social interactions (HP:0000735) | 2.28793308 |
| 68 | Abnormal social behavior (HP:0012433) | 2.28793308 |
| 69 | Intestinal atresia (HP:0011100) | 2.28165497 |
| 70 | Hyperactive renin-angiotensin system (HP:0000841) | 2.27890772 |
| 71 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.26554369 |
| 72 | Hyperphosphatemia (HP:0002905) | 2.25462228 |
| 73 | Abnormality of the corticospinal tract (HP:0002492) | 2.23219131 |
| 74 | Abnormal eating behavior (HP:0100738) | 2.23087618 |
| 75 | Hemiparesis (HP:0001269) | 2.18313442 |
| 76 | Vascular calcification (HP:0004934) | 2.17224704 |
| 77 | Abnormality of vitamin B metabolism (HP:0004340) | 2.16990580 |
| 78 | Postural instability (HP:0002172) | 2.15971557 |
| 79 | Abnormality of renin-angiotensin system (HP:0000847) | 2.12775374 |
| 80 | Hyperkalemia (HP:0002153) | 2.12672576 |
| 81 | Hypoglycemic seizures (HP:0002173) | 2.12646165 |
| 82 | Abnormality of vitamin metabolism (HP:0100508) | 2.12314260 |
| 83 | Sleep apnea (HP:0010535) | 2.09508392 |
| 84 | Diplopia (HP:0000651) | 2.08756359 |
| 85 | Abnormality of binocular vision (HP:0011514) | 2.08756359 |
| 86 | Protruding tongue (HP:0010808) | 2.07979221 |
| 87 | Nephronophthisis (HP:0000090) | 2.06951393 |
| 88 | Spastic gait (HP:0002064) | 2.06915314 |
| 89 | Bradykinesia (HP:0002067) | 2.06725867 |
| 90 | Absent speech (HP:0001344) | 2.05785681 |
| 91 | Gait imbalance (HP:0002141) | 2.04389207 |
| 92 | Limb dystonia (HP:0002451) | 2.03669762 |
| 93 | Macroorchidism (HP:0000053) | 2.02941321 |
| 94 | Cerebral inclusion bodies (HP:0100314) | 2.01995889 |
| 95 | Scanning speech (HP:0002168) | 2.01436604 |
| 96 | Mutism (HP:0002300) | 2.00800809 |
| 97 | Hyperthyroidism (HP:0000836) | 1.99706436 |
| 98 | Syncope (HP:0001279) | 1.96546047 |
| 99 | Psychosis (HP:0000709) | 1.96143853 |
| 100 | Abnormal pancreas size (HP:0012094) | 1.95967946 |
| 101 | Abnormality of the renal cortex (HP:0011035) | 1.95609429 |
| 102 | Neoplasm of the adrenal cortex (HP:0100641) | 1.94881296 |
| 103 | Symptomatic seizures (HP:0011145) | 1.92708954 |
| 104 | Obstructive sleep apnea (HP:0002870) | 1.91406877 |
| 105 | Generalized hypopigmentation of hair (HP:0011358) | 1.90571288 |
| 106 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.89738152 |
| 107 | Postural tremor (HP:0002174) | 1.89439661 |
| 108 | Type II lissencephaly (HP:0007260) | 1.89140782 |
| 109 | Restlessness (HP:0000711) | 1.89006056 |
| 110 | Cortical visual impairment (HP:0100704) | 1.87970768 |
| 111 | Retinal atrophy (HP:0001105) | 1.87860071 |
| 112 | Hypoventilation (HP:0002791) | 1.87394099 |
| 113 | Impaired vibratory sensation (HP:0002495) | 1.87342395 |
| 114 | Pancreatic fibrosis (HP:0100732) | 1.86862636 |
| 115 | Hyperaldosteronism (HP:0000859) | 1.86596508 |
| 116 | Abnormality of salivation (HP:0100755) | 1.85890070 |
| 117 | Increased CSF protein (HP:0002922) | 1.85821814 |
| 118 | Urethral obstruction (HP:0000796) | 1.85812837 |
| 119 | Stereotypic behavior (HP:0000733) | 1.85544847 |
| 120 | Neurofibrillary tangles (HP:0002185) | 1.85401581 |
| 121 | Torticollis (HP:0000473) | 1.85017443 |
| 122 | Resting tremor (HP:0002322) | 1.84628942 |
| 123 | Ketosis (HP:0001946) | 1.84568194 |
| 124 | Calf muscle hypertrophy (HP:0008981) | 1.83826501 |
| 125 | Muscular hypotonia of the trunk (HP:0008936) | 1.83343649 |
| 126 | Menstrual irregularities (HP:0000858) | 1.81770159 |
| 127 | Akinesia (HP:0002304) | 1.81048053 |
| 128 | Bronchiectasis (HP:0002110) | 1.79907076 |
| 129 | Late onset (HP:0003584) | 1.79773682 |
| 130 | Exotropia (HP:0000577) | 1.79733999 |
| 131 | Retinal dysplasia (HP:0007973) | 1.78351730 |
| 132 | Polyphagia (HP:0002591) | 1.78273995 |
| 133 | Hypercortisolism (HP:0001578) | 1.77958791 |
| 134 | Urinary urgency (HP:0000012) | 1.77704992 |
| 135 | Medial flaring of the eyebrow (HP:0010747) | 1.76631616 |
| 136 | Polydipsia (HP:0001959) | 1.76130660 |
| 137 | Abnormal drinking behavior (HP:0030082) | 1.76130660 |
| 138 | Methylmalonic acidemia (HP:0002912) | 1.75694467 |
| 139 | Dysmetric saccades (HP:0000641) | 1.75437249 |
| 140 | Abnormality of the renal medulla (HP:0100957) | 1.75431993 |
| 141 | Septate vagina (HP:0001153) | 1.75323813 |
| 142 | Papillary thyroid carcinoma (HP:0002895) | 1.75306987 |
| 143 | Bronchomalacia (HP:0002780) | 1.73740847 |
| 144 | Open mouth (HP:0000194) | 1.72302169 |
| 145 | Bradycardia (HP:0001662) | 1.71922517 |
| 146 | Congenital primary aphakia (HP:0007707) | 1.71861613 |
| 147 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.71623341 |
| 148 | Gait ataxia (HP:0002066) | 1.70721949 |
| 149 | Specific learning disability (HP:0001328) | 1.70257341 |
| 150 | Prolonged QT interval (HP:0001657) | 1.69799857 |
| 151 | Intention tremor (HP:0002080) | 1.68988909 |
| 152 | Lower limb muscle weakness (HP:0007340) | 1.68932355 |
| 153 | Abnormal EKG (HP:0003115) | 1.68906258 |
| 154 | Progressive inability to walk (HP:0002505) | 1.68446134 |
| 155 | Neuronal loss in central nervous system (HP:0002529) | 1.68036159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.01677202 |
| 2 | MAP3K9 | 3.35607407 |
| 3 | MAP3K4 | 3.15143560 |
| 4 | CAMK1D | 3.10144699 |
| 5 | MARK1 | 2.76310891 |
| 6 | EPHA4 | 2.73850296 |
| 7 | CASK | 2.54474366 |
| 8 | MAP2K7 | 2.49996139 |
| 9 | NTRK1 | 2.38304425 |
| 10 | TNK2 | 2.31588296 |
| 11 | MINK1 | 2.30867468 |
| 12 | INSRR | 2.25657488 |
| 13 | FGFR2 | 2.13800850 |
| 14 | AKT3 | 2.02019135 |
| 15 | PRKD3 | 1.92569179 |
| 16 | MAP3K2 | 1.91913492 |
| 17 | DAPK2 | 1.89582152 |
| 18 | FRK | 1.88947006 |
| 19 | RIPK4 | 1.87523230 |
| 20 | NTRK2 | 1.86807520 |
| 21 | CAMKK2 | 1.81489896 |
| 22 | STK39 | 1.71380546 |
| 23 | MAP2K4 | 1.71168827 |
| 24 | TAOK3 | 1.66663817 |
| 25 | PAK6 | 1.64934595 |
| 26 | KSR2 | 1.62632917 |
| 27 | PNCK | 1.61323910 |
| 28 | GRK1 | 1.56988660 |
| 29 | MAP3K12 | 1.52395725 |
| 30 | CAMKK1 | 1.51687514 |
| 31 | MST4 | 1.48567247 |
| 32 | MAPK13 | 1.46287186 |
| 33 | GRK5 | 1.44689973 |
| 34 | ARAF | 1.40651298 |
| 35 | CDK5 | 1.38568991 |
| 36 | UHMK1 | 1.38473605 |
| 37 | DAPK1 | 1.26593577 |
| 38 | SCYL2 | 1.26324609 |
| 39 | PRKCI | 1.22127149 |
| 40 | STK38L | 1.19895316 |
| 41 | KSR1 | 1.19750192 |
| 42 | MAP2K6 | 1.19660882 |
| 43 | SGK2 | 1.15010334 |
| 44 | WNK3 | 1.14111439 |
| 45 | TNIK | 1.11009685 |
| 46 | PLK2 | 1.10773718 |
| 47 | PINK1 | 1.10500989 |
| 48 | CAMK2A | 1.07864720 |
| 49 | FGFR3 | 1.05477721 |
| 50 | SGK494 | 1.05225396 |
| 51 | SGK223 | 1.05225396 |
| 52 | PRKCG | 1.03418455 |
| 53 | RET | 0.98730354 |
| 54 | BMPR2 | 0.98357774 |
| 55 | CDC42BPA | 0.97262036 |
| 56 | CAMK1G | 0.97087112 |
| 57 | STK38 | 0.96062179 |
| 58 | CAMK2B | 0.94683638 |
| 59 | HIPK2 | 0.94612415 |
| 60 | EEF2K | 0.93762931 |
| 61 | PAK3 | 0.93613526 |
| 62 | MAP3K1 | 0.93171476 |
| 63 | PRKCH | 0.92287980 |
| 64 | PRKD2 | 0.92219855 |
| 65 | MAP4K2 | 0.88606743 |
| 66 | EPHA2 | 0.87577148 |
| 67 | EPHA3 | 0.84054766 |
| 68 | BRAF | 0.83970013 |
| 69 | SGK3 | 0.81884622 |
| 70 | CSNK1G2 | 0.78739403 |
| 71 | PRKCE | 0.75298764 |
| 72 | PRPF4B | 0.73904803 |
| 73 | SGK1 | 0.73535801 |
| 74 | FER | 0.72588326 |
| 75 | CSNK1G1 | 0.71802239 |
| 76 | CAMK2D | 0.70551551 |
| 77 | CAMK1 | 0.69375494 |
| 78 | FES | 0.69015050 |
| 79 | SIK2 | 0.68139506 |
| 80 | NLK | 0.67845170 |
| 81 | PHKG2 | 0.67731830 |
| 82 | PHKG1 | 0.67731830 |
| 83 | MARK2 | 0.67176749 |
| 84 | WNK1 | 0.66201163 |
| 85 | ERBB3 | 0.63752186 |
| 86 | STK11 | 0.63484498 |
| 87 | RPS6KA2 | 0.62521763 |
| 88 | ACVR1B | 0.61025155 |
| 89 | NEK6 | 0.60031896 |
| 90 | OXSR1 | 0.59563603 |
| 91 | PRKAA2 | 0.58198184 |
| 92 | MAP3K13 | 0.58155808 |
| 93 | BMPR1B | 0.58110318 |
| 94 | DYRK1A | 0.56123571 |
| 95 | CSNK1E | 0.54427904 |
| 96 | NME1 | 0.54329995 |
| 97 | PTK2 | 0.54000248 |
| 98 | IRAK2 | 0.53894974 |
| 99 | CSNK1G3 | 0.53636901 |
| 100 | ADRBK2 | 0.52959761 |
| 101 | BCR | 0.52536100 |
| 102 | WNK4 | 0.52394637 |
| 103 | LATS2 | 0.52224466 |
| 104 | RPS6KA3 | 0.52137869 |
| 105 | RAF1 | 0.51300244 |
| 106 | PDPK1 | 0.49565496 |
| 107 | CDK19 | 0.49498080 |
| 108 | PDK1 | 0.48410730 |
| 109 | CSNK1A1 | 0.47430948 |
| 110 | CDK14 | 0.46190121 |
| 111 | LMTK2 | 0.46055984 |
| 112 | PASK | 0.45408640 |
| 113 | YES1 | 0.44973158 |
| 114 | CDK18 | 0.44599400 |
| 115 | TAOK1 | 0.43678766 |
| 116 | CAMK2G | 0.43572020 |
| 117 | MAPK10 | 0.43176253 |
| 118 | STK3 | 0.43113924 |
| 119 | MAP2K1 | 0.43108449 |
| 120 | TRPM7 | 0.42227889 |
| 121 | MAPK15 | 0.41791442 |
| 122 | MKNK2 | 0.41604182 |
| 123 | ADRBK1 | 0.41122532 |
| 124 | STK24 | 0.41014164 |
| 125 | CDK15 | 0.40754453 |
| 126 | CSNK1A1L | 0.40135131 |
| 127 | PTK2B | 0.39103206 |
| 128 | GRK7 | 0.38505424 |
| 129 | PRKCB | 0.37335206 |
| 130 | PRKG1 | 0.36736080 |
| 131 | PRKACA | 0.35741310 |
| 132 | PRKCZ | 0.34973693 |
| 133 | PRKAA1 | 0.34770606 |
| 134 | CSNK1D | 0.33347319 |
| 135 | ERBB2 | 0.32319588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.23197691 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.98922595 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.80685413 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.47518844 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.46434505 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46432494 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.45106210 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.42913973 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.23416157 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.22348810 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.22163652 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.18107658 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.11024244 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10372369 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.08842875 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 2.06641867 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.94889316 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87414800 |
| 19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.86651770 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.82826768 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.79270438 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75883065 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.70874142 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.70172739 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.67045349 |
| 26 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.64263078 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.61324796 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60911100 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.58502742 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45554960 |
| 31 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.42845830 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42513635 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.41118399 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35501827 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34185497 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34160529 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31264834 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30339547 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.25073419 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.24419907 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22636756 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20699922 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18385578 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15762116 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15527862 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.13959581 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.13423572 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10324432 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09702671 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09245987 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.07089196 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06600383 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06237939 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03655970 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.03165463 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02460185 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02349359 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96785694 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95305448 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95017107 |
| 61 | Glioma_Homo sapiens_hsa05214 | 0.93289656 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.93137609 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92514510 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.90803640 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88340110 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88319784 |
| 67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85897820 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84572281 |
| 69 | Protein export_Homo sapiens_hsa03060 | 0.82555374 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79648614 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79251619 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76257331 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75634631 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75148053 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74919072 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.74473440 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73634518 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71894933 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71123994 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.71004292 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69930175 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.67762324 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65313678 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65007310 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64193357 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63194962 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62567056 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62280755 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61834929 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60714303 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60358454 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60270194 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59705940 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59439783 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59079437 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58273237 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.57954450 |
| 98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56910441 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56856540 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.55166391 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52712729 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52675747 |
| 103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52622618 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50789966 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49619500 |
| 106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49492113 |
| 107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49333181 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48554474 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48400171 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48252471 |
| 111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47839265 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47643666 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47344449 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45149033 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45043757 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44598724 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44440986 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42533667 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42244640 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.42114860 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.42097331 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41999939 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.39669395 |
| 124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39317079 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38098262 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37888356 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37779683 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37648006 |
| 129 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33133471 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32124807 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.31496412 |
| 132 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31158334 |
| 133 | Bile secretion_Homo sapiens_hsa04976 | 0.29027434 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.28675682 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28328856 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.26623048 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24154445 |

